N
QURE icon

Nuveen’s uniQure QURE Stock Holding History

Nuveen’s Portfolio QURE Stock Details QURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-52,988
Closed -$607K – 3233
2023
Q2 		$607K Buy
52,988
+1,552
+3% +$29.4K ﹤0.01% 2865
2023
Q1 		$1.04M Buy
51,436
+3,535
+7% +$74.2K ﹤0.01% 2599
2022
Q4 		$1.09M Buy
47,901
+1,218
+3% +$26.3K ﹤0.01% 2651
2022
Q3 		$876K Sell
46,683
-695
-1% -$14.6K ﹤0.01% 2807
2022
Q2 		$883K Buy
47,378
+11,531
+32% +$183K ﹤0.01% 2843
2022
Q1 		$620K Buy
35,847
+4,967
+16% +$86.7K ﹤0.01% 2951
2021
Q4 		$640K Sell
30,880
-4,295
-12% -$123K ﹤0.01% 3003
2021
Q3 		$1.13M Buy
+35,175
New +$1.07M ﹤0.01% 2953

Other funds holding QURE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return